Update on immunology of head and neck cancerKATZ, A. E.The Medical clinics of North America. 1993, Vol 77, Num 3, pp 625-631, issn 0025-7125Article

The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy : molecular staging of prostate cancerOLSSON, C. A; DE VRIES, G. M; BENSON, M. C et al.British journal of urology (Print). 1996, Vol 77, Num 3, pp 411-417, issn 0007-1331Article

Cheek-neck advancement-rotation flaps following Mohs excision of skin malignanciesKATZ, A. E; GRANDE, D. J.The Journal of dermatologic surgery and oncology. 1986, Vol 12, Num 9, pp 949-955, issn 0148-0812Article

Plasma exchange in six patients with advanced cancers of the head and neckSEDER, R. H; KATZ, A. E; KEGGINS, J. J et al.Journal of clinical apheresis (Print). 1985, Vol 2, Num 3, pp 238-249, issn 0733-2459Article

Microvessel density as a predictor of PSA recurrence after radical prostatectomy : A comparison of CD34 and CD31DE LA TAILLE, A; KATZ, A. E; BAGIELLA, E et al.American journal of clinical pathology. 2000, Vol 113, Num 4, pp 555-562, issn 0002-9173Article

Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen : Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomyDE LA TAILLE, A; OLSSON, C. A; BUTTYAN, R et al.International journal of cancer. 1999, Vol 84, Num 4, pp 360-364, issn 0020-7136Article

Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay. Commentary. Authors' replyPRICE, D. K; CLONTZ, D. R; WOODARD, W. L et al.Urology (Ridgewood, NJ). 1998, Vol 52, Num 2, pp 261-267, issn 0090-4295Article

Pretreatment prostate specific antigen doubling times : Use in patients before radical prostatectomy. CommentaryGOLUBOFF, E. T; HEITJAN, D. F; DEVRIES, G. M et al.The Journal of urology. 1997, Vol 158, Num 5, pp 1876-1879, issn 0022-5347Article

Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancerSEDER, R. H; VAUGHAN, C. W; SE-KYUNG OH et al.Cancer. 1987, Vol 60, Num 3, pp 318-325, issn 0008-543XArticle

Induction bleomycin infusion in head and neck cancerPOPKIN, J. D; HONG, W. K; BROMER, R. H et al.American journal of clinical oncology. 1984, Vol 7, Num 3, pp 199-204, issn 0277-3732Article

Salvage cryotherapy for recurrent prostate cancer after radiation therapy : The columbia experienceDE LA TAILLE, A; HAYEK, O; BENSON, M. C et al.Urology (Ridgewood, NJ). 2000, Vol 55, Num 1, pp 79-84, issn 0090-4295Article

Expérience de l'Université de Columbia dans la détection des cellules circulantes par RT-PCR PSA dans le cancer de prostate comme facteur prédictif du stade et de la récurrence biologique = Columbia University experience of detection of circulating cells by RT-PCR PSA in prostate cancer as a predictive factor of stage and biochemical recurrenceDE LA TAILLE, A; OLSSON, C. A; BUTTYAN, R et al.Progrès en urologie (Paris). 1999, Vol 9, Num 3, pp 555-561, issn 1166-7087Article

The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancerNEJAT, R. J; KATZ, A. E; OLSSON, C. A et al.Seminars in urologic oncology. 1998, Vol 16, Num 1, pp 40-45, issn 1081-0943Article

Expression of the tumor-associated gene MN : A potential biomarker for human renal cell carcinomaMCKIERNAN, J. M; BUTTYAN, R; BANDER, N. H et al.Cancer research (Baltimore). 1997, Vol 57, Num 12, pp 2362-2365, issn 0008-5472Article

Molecular staging of prostate cancer. II: A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigenCAMA, C; OLSSON, C. A; RAFFO, A. J et al.The Journal of urology. 1995, Vol 153, Num 5, pp 1373-1378, issn 0022-5347Article

The purse-string suture in facial reconstructionBRADY, J. G; GRANDE, D. J; KATZ, A. E et al.The Journal of dermatologic surgery and oncology. 1992, Vol 18, Num 9, pp 812-816, issn 0148-0812Conference Paper

Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injuryBANDYK, M. G; SAWCZUK, I. S; OLSSON, C. A et al.The Journal of urology. 1990, Vol 143, Num 2, pp 407-413, issn 0022-5347Article

Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma independence from other pretreatment characteristicsENNIS, R. D; KATZ, A. E; DE VRIES, G. M et al.Cancer. 1997, Vol 79, Num 12, pp 2402-2408, issn 0008-543XArticle

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancerDORAI, T; OLSSON, C. A; KATZ, A. E et al.The Prostate. 1997, Vol 32, Num 4, pp 246-258, issn 0270-4137Article

Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samplesSUN, Y; LIN, J; KATZ, A. E et al.Cancer research (Baltimore). 1997, Vol 57, Num 1, pp 18-23, issn 0008-5472Article

Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. CommentaryCAMA, C; OLSSON, C. A; BUTTYAN, R et al.The Journal of urology. 1997, Vol 157, Num 5, pp 1748-1751, issn 0022-5347Article

Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomyOLSSON, C. A; DE VRIES, G. M; RAFFO, A. J et al.The Journal of urology. 1996, Vol 155, Num 5, pp 1557-1562, issn 0022-5347Article

Massive cystic heterotopic brain tissueAPRIL, M. M; SEYMOUR, B. T; DUBOYS, E et al.International journal of pediatric otorhinolaryngology. 1994, Vol 28, Num 2-3, pp 235-239, issn 0165-5876Article

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assayKATZ, A. E; OLSSON, C. A; RAFFO, A. J et al.Urology (Ridgewood, NJ). 1994, Vol 43, Num 6, pp 765-775, issn 0090-4295Article

Anti-prostate cancer activity of a β-carboline alkaloid enriched extract from Rauwolfia vomitoriaBEMIS, D. L; CAPODICE, J. L; GORROOCHURN, P et al.International journal of oncology. 2006, Vol 29, Num 5, pp 1065-1073, issn 1019-6439, 9 p.Article